Oleanolic Acid Attenuates Insulin Resistance via NF-κB to Regulate the IRS1-GLUT4 Pathway in HepG2 Cells

Area of Science:

• Biochemistry
• Cell Biology
• Metabolic Diseases

Background:

• Insulin resistance (IR) is a key factor in metabolic disorders.
• HepG2 cells are a valuable model for studying liver insulin resistance.
• Oleanolic acid (OA) is a natural compound with potential therapeutic benefits.

Purpose of the Study:

• To elucidate the mechanisms by which oleanolic acid (OA) combats insulin resistance (IR) in HepG2 cells.
• To investigate the role of inflammatory cytokines and key protein pathways in OA's effects on IR.

Main Methods:

• HepG2 cells were induced into an insulin resistance model using free fatty acids (FFA).
• Cells were treated with oleanolic acid (OA).
• Glucose content, inflammatory cytokine levels (TNF-α, IL-6), and protein expression (NF-κB, IRS1, GLUT4) were analyzed using Western blot. NF-κB pathway was blocked using PDTC to assess its role.

Main Results:

• Oleanolic acid (OA) decreased glucose content and levels of tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) in insulin-resistant HepG2 cells.
• OA upregulated the protein expression of insulin receptor substrate 1 (IRS1) and glucose transporter 4 (GLUT4).
• OA reduced nuclear factor kappa B (NF-κB) protein expression; blocking NF-κB diminished OA's effect on IRS1 expression, indicating NF-κB's crucial role.

Conclusions:

• Oleanolic acid (OA) effectively attenuates insulin resistance in HepG2 cells.
• OA exerts its beneficial effects by reducing inflammation and improving glucose metabolism.
• The mechanism involves regulating the IRS1-GLUT4 pathway through the modulation of NF-κB signaling.